BioTelemetry's net profit under GAAP for 9 months of 2020 was $16.104 million, which is 43% lower compared to $28.268 million in the previous year. Revenue decreased by 0.1% to $326.795 million from $327.073 million a year earlier.
BioTelemetry's net profit under GAAP for 9 months of 2020 was $16.104 million, which is 43% lower compared to $28.268 million in the previous year. Revenue decreased by 0.1% to $326.795 million from $327.073 million a year earlier. 
investors.gobio.com
English (US) 